Colorado BioResearch Product Faire™
Construction is underway on the new Anschutz Health Sciences building at the University of Colorado Anschutz Medical Campus. The building, which is expected to open in 2021, is in a gateway location at the western border of campus in Aurora. Providing 390,000 square feet of space for research programs and education, the building will become one of the largest and most advanced medical campuses in the nation.Read More
Colorado University Anschutz Medical Campus and its partner, Colorado Clinical and Transitional Sciences Institute (CCTSI), recently received a new five-year $46.5 million grant from the National Institute of Health (NIH).
“The general public may not know the CCTSI name,” Dr. Sokol, CCTSI director and professor of pediatrics in the School of Medicine, stated in an article for CU Anschutz Today. “But they have probably benefited from the research that has come out of our institute over the past 10 years.”
Since its inception, Institute staff have conducted research that has led to a cure for hepatitis C; developed treatments for cystic fibrosis; boosted the rates of health screenings in underserved Colorado communities; and developed community-based approaches to teaching CPR.Read More
Tags: direct access to researchers, University of Colorado Anschutz Medical Campus, BioResearch Product Faire Event, Colorado, life science equipment sales, NIH grants, life science market, Fitz, 2018, clinical and translational research funding, nih research funding
A $3.8 million award from the U.S. Department of Defense (DOD) gives researchers at the Gates Center for Regenerative Medicine on the University of Colorado Anschutz Medical Center campus the opportunity to move into the manufacture of stem cell-created skin grafts.Read More
Tags: direct access to researchers, University of Colorado Anschutz Medical Campus, BioResearch Product Faire Event, Colorado, life science equipment sales, life science market, Fitz, 2018, stem cell science, Dental Public Health
The University of Colorado Anschutz Medical Center has been awarded a five-year, $46.5 million NIH grant to continue groundbreaking research programs at its Colorado Clinical and Translational Science Institute (CCTSI).Read More
Blog updated on 6/14/2016.Read More
Diabetes encompasses a group of metabolic disorders that result in chronically elevated blood sugar levels. If untreated, these diseases can result in serious complications such as ketoacidosis, heart disease, kidney failure, and stroke. The most common type of diabetes is type II diabetes, which accounts for 90-95% of cases (a recent Philadelphia study helped us gain further insight into why type II diabetes occurs). The incidence of type I diabetes is much lower, accounting for just 5-10% of cases. However, while type II diabetes can resolve on its own with changes in diet and exercise habits, type I is considered incurable. Now, a new study from the University of Colorado, Anschutz Medical Campus has identified a new class of antigens that may be a factor in the development of the disease.Read More
Nearly everyone in the world knows someone who has cataracts or will get cataracts themselves sometime in life. Cataracts, the most common cause of vision impairment, cloud the lens inside the eye and make it difficult to see. Although surgery can be performed to replace the clouded lens in the eye, it is both costly and challenging for surgeons to perform. (Image of eye by 8thstar via Wikimedia Commons).Read More
In 1930 when Doctor Samuel Fosdick Jones retired from his medical practice and teaching at the University of Colorado, the field of bone pathology research was new and emerging. In order to help support this research area, he set up a trust fund that, years after his death, would grant the University of Colorado funding to use in support of this research field. (Image courtesy of Wikimedia Commons).Read More
The University of Colorado has announced an outstanding $1.521 billion in funding from the private sector through their Creating Futures fundraising project. This effort, CU's 4th fundraising campaign, began quietly in July 2006 and was publically announced in April 2011 after over $900 million had been raised through the generosity of over 115,000 sources. Since the campaign went public, the university has broadened its target audience to include CU alumni and even more individuals relevant to CU's campaign efforts. As of September 30th, CU had received a total of over $1.5 billion, with $722 million going to CU Anschutz Medical Campus and $84 million going to CU Denver.